DrugPatentWatch Database Preview

ADDERALL XR 20 Drug Profile

« Back to Dashboard

When do Adderall Xr 20 patents expire, and when can generic versions of Adderall Xr 20 launch?

Adderall Xr 20 is a drug marketed by Shire and is included in one NDA. There are four patents protecting this drug.

This drug has ten patent family members in eight countries.

The generic ingredient in ADDERALL XR 20 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.

Summary for ADDERALL XR 20

International Patents:	10
US Patents:	4
Applicants:	1
NDAs:	1
Suppliers / Packagers:	6
Bulk Api Vendors:	1
Clinical Trials:	33
Formulation / Manufacturing:	see details
DailyMed Link:	ADDERALL XR 20 at DailyMed

Pharmacology for ADDERALL XR 20

Drug Class	Central Nervous System Stimulant
Physiological Effect	Central Nervous System Stimulation

Synonyms for ADDERALL XR 20

24 HR Amphetamine aspartate

ADDERALL 10

ADDERALL 12.5

ADDERALL 15

ADDERALL 20

ADDERALL 30

ADDERALL 5

ADDERALL 7.5

ADDERALL XR 10

ADDERALL XR 15

ADDERALL XR 25

ADDERALL XR 30

ADDERALL XR 5

Adzenys XR-ODT

Amphetamine aspartate mixture with amphetamine sulfate, dextroamphetamine saccharate and dextroamphetamine sulfate

Dextroamphetamine sulfate mixture with dextroamphetamine saccharate and amphetamine aspartate monohydrate and amphetamine sulfate

S900000010

US Patents and Regulatory Information for ADDERALL XR 20

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire	ADDERALL XR 20	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-002	Oct 11, 2001	AB	RX	Yes	No					Y
Shire	ADDERALL XR 20	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-002	Oct 11, 2001	AB	RX	Yes	No					Y
Shire	ADDERALL XR 20	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-002	Oct 11, 2001	AB	RX	Yes	No					Y
Shire	ADDERALL XR 20	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	021303-002	Oct 11, 2001	AB	RX	Yes	No					Y

International Patents for ADDERALL XR 20

Country	Patent Number	Estimated Expiration
Germany	69940673
Austria	427101
World Intellectual Property Organization (WIPO)	0023055
European Patent Office	1123087
European Patent Office	1977736
Australia	1214500
Japan	2008303223